Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05694676
Other study ID # 11-2022/02
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 17, 2023
Est. completion date October 11, 2023

Study information

Verified date December 2023
Source Karamanoglu Mehmetbey University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.


Description:

Depression and anxiety symptoms are common during pregnancy and are estimated to affect 7% - 20% of pregnant women, constituting significant risks for mothers and babies. Depression and anxiety may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. Increasing evidence shows that prenatal exposure to maternal depression and anxiety is associated with several lifelong adverse outcomes in children, including physical health problems, emotional and behavioral difficulties, and low verbal IQ. Such maladaptive outcomes are thought to have a neurobiological basis and there is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. However, what is more important is that the neurological footprints of these structural changes on the young brain can be caught early in life. The neurological status of infants can be determined early in life by video assessment of General Movements (GMs) quality. In this study at the age of 3 months, a video assessment of the quality of GMs will be performed to evaluate neurologic conditions.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date October 11, 2023
Est. primary completion date October 11, 2023
Accepts healthy volunteers
Gender All
Age group 10 Weeks to 20 Weeks
Eligibility Mothers Inclusion Criteria: - Mothers aged 18 to 40 years, - Singleton pregnancy - No smoking during prengnancy - No illicit drug or alcohol use during pregnancy, - No major health conditions requiring invasive treatments (e.g., dialysis, blood transfusions, chemotherapy), - No diagnosis of psychotic illnesses (eg, schizophrenia,bipolar or borderline personality disorder), and - No major autoimmune diseases - No pregnancy-related complications: (including prenatal infection, pregnancy-included hypertension, gestational diabetes, oligohydramnios, polyhydramnios, preterm labor, vaginal bleeding, placenta previa, or anemia). Infant inclusionary criteria: - infants were born at 36-42 wk of gestation - uncomplicated singleton birth, - no pre-existing neurologic conditions or major head trauma, neonatal intensive care unit stay limited to observation only (ie, no interventions), and - infant discharged from the hospital with the mother. Mothers Exclusion Criteria: - post partum depression and/or anxiety - delivery complication Infant exclusion criteri: - infant birth before 36 weeks gestation - infant weight lower 2500gr at birth - Apgar score 0f <7 at 5 minutes - Major neonatal complications - Identified neurologic, genetic or congenital syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Assessment of the quality of Genaral Movements (GMs)
The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
State-Trait Anxiety Inventory-Trait, (STAI-T)
The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
Beck Depression Inventory, (BDI)
BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression

Locations

Country Name City State
Turkey Karaman Training and Research Hospital Karaman

Sponsors (2)

Lead Sponsor Collaborator
Karamanoglu Mehmetbey University Karaman Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Relationship Between Prenatal Maternal Anxiety and the Quality of General Movements Univariate statistical analyses will be performed to calculate differences in mothers' STAI-T scores between children with normal and abnormal GMs. 3-5 months
Primary Relationship Between Prenatal Maternal Depression and the Quality of General Movements Univariate statistical analyses will be performed to calculate differences in mothers' BDI scores between children with normal and abnormal GMs. 3-5 months
Secondary Multivariate analyses will be carried out with control variables Significant primary outcome measures will be controlled with:
Maternal age (years)
Maternal education (Literate, Elementary school, Middle School, High school, University)
Marital status (married, separated, divorced, widow)
Maternal height (m)
Maternal weight before pregnancy (kg)
Maternal weight at birth (kg)
Maternal BMI before pregnancy (Maternal weight before pregnancy/Maternal height) (kg/m^2)
Maternal BMI at birth (Maternal weight at birth/Maternal height)(kg/m^2)
Type of delivery (Vaginal spontaneous, Instrumental, Assisted vaginal, Elective C/S, Emergency C/S),
Birth order
Gestational age at birth (days)
Infant birth weight (grams)
Infant birth height (cm)
Infant birth head circumference (cm)
Infant gender (boy, girl)
Infant 1st and 5th minute Apgar scores
Breastfeeding (>6wk, <=6 wk)
3-5 months
See also
  Status Clinical Trial Phase
Recruiting NCT05317234 - Genetic Predisposition in Cerebral Palsy N/A
Recruiting NCT05576948 - Natural History of Cerebral Palsy Prospective Study
Completed NCT04119063 - Evaluating Wearable Robotic Assistance on Gait Early Phase 1
Completed NCT03264339 - The Small Step Program - Early Intervention for Children With High Risk of Developing Cerebral Palsy N/A
Completed NCT05551364 - Usability and Effectiveness of the ATLAS2030 Exoskeleton in Children With Cerebral Palsy N/A
Completed NCT03902886 - Independent Walking Onset of Children With Cerebral Palsy
Recruiting NCT05571033 - Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy N/A
Not yet recruiting NCT04081675 - Compliance in Children With Cerebral Palsy Supplied With AFOs
Completed NCT02167022 - Intense Physiotherapies to Improve Function in Young Children With Cerebral Palsy N/A
Completed NCT04012125 - The Effect of Flexible Thoracolumbar Brace on Scoliosis in Cerebral Palsy N/A
Enrolling by invitation NCT05619211 - Piloting Movement-to-Music With Arm-based Sprint-Intensity Interval Training Among Children With Physical Disabilities Phase 1
Completed NCT04489498 - Comparison of Somatometric Characteristics Between Cerebral Palsy and Normal Children, Cross-sectional, Multi Center Study
Completed NCT03677193 - Biofeedback-enhanced Interactive Computer-play for Youth With Cerebral Palsy N/A
Recruiting NCT06450158 - Robot-assisted Training in Children With CP N/A
Completed NCT04093180 - Intensive Neurorehabilitation for Cerebral Palsy N/A
Completed NCT02909127 - The Pediatric Eating Assessment Tool
Not yet recruiting NCT06377982 - Human Umbilical Cord Blood Infusion in Patients With Cerebral Palsy Phase 1
Not yet recruiting NCT06007885 - Examining Capacity Building of Youth With Physical Disabilities to Pursue Participation Following the PREP Intervention. N/A
Not yet recruiting NCT03183427 - Corpus Callosum Size in Patients With Pineal Cyst N/A
Active, not recruiting NCT03078621 - Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy Phase 1/Phase 2